Strength to be evaluated for Canada submssion [Regulatives / Guidelines]

posted by Compliance – India, 2014-04-23 18:35 (4446 d 00:04 ago) – Posting: # 12877
Views: 2,933

Dear All,

I gone through the both guidance of the Canada to find out on which strength the BE study should be performed. But i could not get any idea however there is clarity found about the strength to be use if drug does not follows linear kinetic.

Kindly advice, is it acceptable if i conduct study on highest strength for a drug which follows linear kinetic? or kindly suggest me any reference in which i can get such information.

Regards,

Compliance

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
136 visitors (0 registered, 136 guests [including 24 identified bots]).
Forum time: 18:39 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5